0
Pulmonology Procedures |

Bronchoscopic Detection of Lung Cancer With Porphysome Nanoparticle-Based Contrast Enhancement and a Prototype Fluorescent Bronchoscope

Takashi Anayama*, PhD; Patrick McVeigh, MA; Cheng Jin, MA; Takahiro Nakajima, PhD; Brian Wilson, PhD; Gang Zheng, PhD; Shaf Keshavjee, MS; Kazuhiro Yasufuku, PhD
Author and Funding Information

Latner Thoracic Surgery Research Laboratory, Division of Thoracic Surgery, Department of Surgery, Toronto General Hospital, University Health Network, Toronto, ON, Canada


Chest. 2012;142(4_MeetingAbstracts):926A. doi:10.1378/chest.1389685
Text Size: A A A
Published online

Abstract

SESSION TYPE: Biomarkers, Oncogenes and Enhanced Bronchoscopy in NSCLC

PRESENTED ON: Wednesday, October 24, 2012 at 02:45 PM - 04:15 PM

PURPOSE: Recent advances in bronchoscopy such as autofluorescence imaging are useful for detecting early lung cancer (carcinoma in-situ) within the bronchial mucosa. The alternative, to use targeted exogenous fluorophores, has been little explored. Recently discovered multifunctional organic nanoparticles, “Porphysomes”, will accumulate in neoplastic lesions because of the EPR effect. Here, endoscopic lung cancer visualization was examined in orthotopic lung cancer animal models using a prototype bronchoscope designed for imaging near-infrared porphysome fluorescence.

METHODS: A rabbit VX2 orthotopic lung cancer model and nude mouse orthotopic human lung cancer A549 xenograft model were used. Porphysomes were administrated intravenously at a dose of 10 - 30 mg kg-1. Systemic biodistribution and accumulation of the fluorophore in the tumour was analysed in vivo using a small-animal, whole-body imager. The endoscopic field of view was excited with a 650-670nm / 10mW diode light source via the illumination channels and emission light was filtered with a 678nm long pass filter. Fluorescence was recorded using a CCD camera attached to the ocular lens of a bronchofiberscope.

RESULTS: In an in-vitro setting, the prototype fluorescent bronchoscope system could detect the bright fluorescence of the porphysome with a 50uM or higher concentration. In-vivo imaging revealed that the porphysomes accumulate in the orthotopic lung cancers in rabbits and mice, using a 200 ms exposure time, which is compatible with clinical bronchoscopic examination. Ex-vivo studies show that in addition to superficial lesions, porphysome fluorescence from tumours overlaid by a bronchial wall or lung parenchyma 2mm thick was detected by the system.

CONCLUSIONS: Intravenously administrated porphysome nanoparticles successfully accumulated in the orthotopic lung cancers, and the near-infrared nanoparticle fluorescence was successfully detected with a prototype fluorescent endoscope.

CLINICAL IMPLICATIONS: These studies provide promising data to support the technical feasibility of bronchoscopic fluorescence visualization of lung cancers with systemic porphysome administration.

DISCLOSURE: The following authors have nothing to disclose: Takashi Anayama, Patrick McVeigh, Cheng Jin, Takahiro Nakajima, Brian Wilson, Gang Zheng, Shaf Keshavjee, Kazuhiro Yasufuku

We will discuss about our system which is consisted of prototype optical lens changer, CCD camera, diode light source, and bronchofiberscope.

Latner Thoracic Surgery Research Laboratory, Division of Thoracic Surgery, Department of Surgery, Toronto General Hospital, University Health Network, Toronto, ON, Canada

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543